Exenatide clinical trials antidiabetic drugs

AC 2993 - Byetta - AC 2993 LAR - exendin 4 - Ex4 peptide - exendin-4 - bydureon - exenatide

Diabetes type 2

All type of patients:   pinterest powerpoint 10196,12386,12388,10197,12389,10198,12391,12496,12595,10199,12596,12613,12696,10200,12698,12699,10201,12700,10202,12702,10203,12703,12763,10204,12767,10206,12863,12912,10207,11207,12913,11321,11323,12051,12914,12327,12370,12374,12378,12701,12383,12385

Patients inadequately controlled on MET+SU therapy :   pinterest powerpoint 12613,10199,10198,10203

Patients inadequately controlled on metformin:   pinterest powerpoint 12595,10206,10200,12388

Patients inadequately controlled on monotherapy :   pinterest powerpoint 10200,10202,10206,12388,12378,12389,12386,12595,12596

Patients inadequately controlled with insulin:   pinterest powerpoint 10196,10197,10198,10199,11207,12386,12051

Patients with insufficient glycaemic control with bitherapy:   pinterest powerpoint 10198,10199,10201,10203,10204,12613,12496,12385,12378,12388,10196